Evaluation of Periodontal Status in Diabetes Mellitus Type 2 Patients Based on HbA1c and CRP
Journal of "Regeneration, Reconstruction & Restoration" (Triple R),
Vol. 6 (2021),
13 March 2021
Introduction: During the last decades, there has been an increasing interest in the relationship between diabetes mellitus (DM) and periodontitis. Some evidence has suggested that inflammatory factors like C-reactive protein (CRP) can be contributing factors to both periodontitis and diabetes. This study was aimed at assessing periodontal position in diabetes mellitus type 2 patients based on HbA1c and CRP.
Materials and Methods: 76 patients with diabetes mellitus2 (DM2) were divided based on glycemic control: 35 subjects with HbA1c less than 7% and 41 subjects with HbA1c≥7%. The following measurements were conducted: Serum HbA1c and C-reactive protein (CRP), gingival Index (GI), plaque Index (PI), clinical attachment loss (CAL), bleeding on probing (BOP), and probing depth (PD). Moreover, age, gender and duration of diabetes of the patients were also analyzed.
Results: In this study, 24 women and 11 men by mean age of 55/31±8/37 were in a good diabetic patients’ group (HbA1c<7%) and 30 females and 11 males by the mean age of 53/76±9/91 were in poor control diabetic patients (HbA1c≥7%). A significant correlation between the elevation of CRP and increased level of HbA1c was observed (P<0/001). The patients` age was associated with the duration of diabetes (P=0/024) and women had significantly more duration of diabetes than men (P=0/012). Regarding PD, CAL, BOP and PI, there was no significant difference between the analyzed groups. Also, no significant relationship between CRP and periodontal parameters has been found.
Conclusion: CRP was found as a predictor of HbA1c in patients with poor glycemic control. This implies higher infection rates due to diabetes.
- Diabetes Mellitus
- Periodontal Disease
- C- reactive protein
How to Cite
2. Petersen PE. Global policy for improvement of oral health in the 21st century--implications to oral health research of World Health Assembly 2007, World Health Organization. Community dentistry and oral epidemiology. 2009;37(1):1-8.
3. Katagiri S, Nitta H, Nagasawa T, Uchimura I, Izumiyama H, Inagaki K, et al. Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diabetes research and clinical practice. 2009;83(3):308-15.
4. AlJehani YA. Risk factors of periodontal disease: review of the literature. International journal of dentistry. 2014;2014:182513-.
5. Albandar JM, Tinoco EM. Global epidemiology of periodontal diseases in children and young persons. Periodontology 2000. 2002;29:153-76.
6. Ogawa H, Yoshihara A, Amarasena N, Hirotomi T, Miyazaki H. Association between serum albumin and periodontal disease in community-dwelling elderly. Journal of clinical periodontology. 2006;33(5):312-6.
7. Engebretson S, Gelato M, Hyman L, Michalowicz BS, Schoenfeld E. Design features of the Diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis. Contemporary clinical trials. 2013;36(2):515-26.
8. Tsobgny-Tsague NF, Lontchi-Yimagou E, Nana ARN, Tankeu AT, Katte JC, Dehayem MY, et al. Effects of nonsurgical periodontal treatment on glycated haemoglobin on type 2 diabetes patients (PARODIA 1 study): a randomized controlled trial in a sub-Saharan Africa population. BMC oral health. 2018;18(1):28.
9. Wang S, Liu J, Zhang J, Lin J, Yang S, Yao J, et al. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis. Brazilian oral research. 2017;31:e90.
10. Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes & metabolic syndrome. 2019;13(1):800-4.
11. Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, et al. Inflammatory Markers and Risk of Type 2 Diabetes. A systematic review and meta-analysis. 2013;36(1):166-75.
12. Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. Journal of leukocyte biology. 2005;78(4):862-70.
13. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21-31.
14. Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G. Diabetes and periodontal disease: a case-control study. Journal of periodontology. 2005;76(3):418-25.
15. Lim LP, Tay FB, Sum CF, Thai AC. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. Journal of clinical periodontology. 2007;34(2):118-23.
16. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. Journal of periodontology. 1981;52(4):167-73.
17. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes research and clinical practice. 2010;87(1):15-9.
18. Lawrence J, Robinson A. Screening for diabetes in general practice. Preventive cardiology. 2003;6(2):78-84.
19. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;385(9963):117-71.
20. Najafi B, Farzadfar F, Ghaderi H, Hadian M. Cost effectiveness of type 2 diabetes screening: A systematic review. Medical journal of the Islamic Republic of Iran. 2016;30:326-.
21. Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, Ylostalo P. Association between serum lipid levels and periodontal infection. Journal of clinical periodontology. 2008;35(12):1040-7.
22. Sanz M, Ceriello A, Buysschaert M, Chapple I, Demmer RT, Graziani F, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology. Diabetes research and clinical practice. 2018;137:231-41.
23. Cardoso EM, Reis C, Manzanares-Cespedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgraduate medicine. 2018;130(1):98-104.
24. Llambés F, Arias-Herrera S, Caffesse R. Relationship between diabetes and periodontal infection. World journal of diabetes. 2015;6(7):927-35.
25. Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes care. 2010;33(2):421-7.
26. Jones JA, Miller DR, Wehler CJ, Rich SE, Krall-Kaye EA, McCoy LC, et al. Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. Journal of clinical periodontology. 2007;34(1):46-52.
27. Vidova V, Stuchlikova E, Vrbova M, Almasi M, Klanova J, Thon V, et al. Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots. Journal of proteome research. 2018.
28. Paffen E, Vos HL, Bertina RM. C-reactive protein does not directly induce tissue factor in human monocytes. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(5):975-81.
29. Allen EM, Matthews JB, DJ OH, Griffiths HR, Chapple IL. Oxidative and inflammatory status in Type 2 diabetes patients with periodontitis. Journal of clinical periodontology. 2011;38(10):894-901.
30. Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M. Associations of Serum C-reactive Protein with Fasting Insulin, Glucose, and Glycosylated Hemoglobin : The Third National Health and Nutrition Examination Survey, 1988–1994. American Journal of Epidemiology. 2002;155(1):65-71.
31. Kiedrowicz M, Dembowska E, Banach J, Safranow K, Pynka S. A comparison of the periodontal status in patients with type 2 diabetes based on glycated haemoglobin levels and other risk factors. Advances in medical sciences. 2015;60(1):156-61.
32. Susanto H, Nesse W, Dijkstra PU, Hoedemaker E, van Reenen YH, Agustina D, et al. Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c: a study in Indonesia. 2012;16(4):1237-42.
33. Aspriello SD, Zizzi A, Tirabassi G, Buldreghini E, Biscotti T, Faloia E, et al. Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. Journal of periodontal research. 2011;46(2):164-9.
34. Dag A, Firat ET, Arikan S, Kadiroglu AK, Kaplan A. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Australian dental journal. 2009;54(1):17-22.
35. Awartani FA. Evaluation of the relationship between type 2 diabetes and periodontal disease. Saudi medical journal. 2009;30(7):902-6.
36. Santos VR, Lima JA, De Mendonca AC, Braz Maximo MB, Faveri M, Duarte PM. Effectiveness of full-mouth and partial-mouth scaling and root planing in treating chronic periodontitis in subjects with type 2 diabetes. Journal of periodontology. 2009;80(8):1237-45.
37. Santos VR, Ribeiro FV, Lima JA, Napimoga MH, Bastos MF, Duarte PM. Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects. Journal of clinical periodontology. 2010;37(12):1049-58.
38. Santos VR, Lima JA, Miranda TS, Feres M, Zimmermann GS, Nogueira-Filho GdR, et al. Relationship between glycemic subsets and generalized chronic periodontitis in type 2 diabetic Brazilian subjects. Archives of Oral Biology. 2012;57(3):293-9.
39. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. 2002;30(3):182-92.
- Abstract Viewed: 28 times
- PDF Downloaded: 13 times